| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/06/2009 | CN101422543A Traditional Chinese medicine composition for treating psoriasis |
| 05/06/2009 | CN101422505A Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof |
| 05/06/2009 | CN101422500A Immunoenhancement regulator of pig blue-ear disease vaccine and use thereof |
| 05/06/2009 | CN101422487A Bear gall soft capsules and preparation method thereof |
| 05/06/2009 | CN101422476A Animal compound sodium closantel injection |
| 05/06/2009 | CN101422470A Remofovir orally disintegrating tablets and preparation method thereof |
| 05/06/2009 | CN101422468A Medicine combination for treating wound ulceration, scald, bedsore or the like |
| 05/06/2009 | CN101422464A Compound fubennikao injection |
| 05/06/2009 | CN101422461A Preparation method of matrine vagina effervescence tablet and use thereof |
| 05/06/2009 | CN101422460A Preparation method of FK506 slow-release film for repairing nerve damage |
| 05/06/2009 | CN101422458A Epothilone freeze-drying composition |
| 05/06/2009 | CN101422457A Tiotropium bromide respirable dry powder composition |
| 05/06/2009 | CN101422456A Medicine combination drop-pills and preparation method and quality detection method thereof |
| 05/06/2009 | CN101422455A Micro-emulsion injection containing EGCG |
| 05/06/2009 | CN101422454A Omega-3 polyunsaturated fatty acid tanshinone IIA sub-microemulsion and preparation method thereof |
| 05/06/2009 | CN101422440A Hydrochlorothiazide-metroprolol succinate sustained-release drop pills and preparation method thereof |
| 05/06/2009 | CN101422436A Dry powder composite for suction |
| 05/06/2009 | CN101422433A Environment simulating sustained-release storage system and preparation method thereof |
| 05/06/2009 | CN101422431A Insulation administration preparation through nose |
| 05/06/2009 | CN101422429A Water-soluble vitamin for injection and preparation method thereof |
| 05/06/2009 | CN101422426A Nitroimidazoles medicine nano montmorillonite sustained-release agent and preparation method thereof |
| 05/06/2009 | CN101422424A Mycophenolic acid medicine implantation agent and preparation method and use thereof |
| 05/06/2009 | CN100484574C Hydrochloric acid cefetamet pivoxil dispersible tablet and method for preparing the same |
| 05/06/2009 | CN100484573C Method for preparing floating-biological adhesion synergistic microparticle |
| 05/06/2009 | CN100484528C Pharmaceutical composition containing prostaglandin |
| 05/06/2009 | CN100484526C Compounding method of cefpirome sulfate raw material and uses thereof |
| 05/06/2009 | CN100484525C Pantoprazole sodium freeze-dried powder injection and preparing method thereof |
| 05/06/2009 | CN100484521C A nano emulation antibacterial medicine of furacillin and preparation method thereof |
| 05/06/2009 | CN100484516C Cefamandole nafate powder injection, production method of powder injection and raw machine thereof |
| 05/06/2009 | CN100484515C Guacetisal dry-mixing suspending agents and method of preparing the same |
| 05/06/2009 | CN100484513C Grafted nano carbon mixed suspension and its preparing process |
| 05/05/2009 | US7528237 Binding to monoclonal antibodies; antitumor agents |
| 05/05/2009 | US7528234 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent |
| 05/05/2009 | US7528202 At least one end of the polymer has at least two reactive groups attached to a branching atom that is bonded to the polymer through a hydrolytically stable linkage; the free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide |
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7527809 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof |
| 05/05/2009 | US7527807 Compositions and methods for increasing the oral absorption of antimicrobials |
| 05/05/2009 | US7527802 For therapy against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby |
| 05/05/2009 | US7527797 Capsular polysaccharide of Vibrio cholerae O139 covalently bound with an adipic acid dihydrazide linker to a recombinant diphtheria toxin carrier protein eliciting serum vibriocidal antibodies; conjugated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), |
| 05/05/2009 | US7527792 Arg-arg-leu-ser-tyr-ser-arg-arg-arg-phe decapeptide bonded to drug such as doxorubicin via maleimide derivative linkage; preventing chemoresistance or drug resistance; gene expression inhibition of multidrug resistance gene |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | CA2436260C Compositions containing a ruthenium(iii) complex and a heterocycle |
| 05/05/2009 | CA2417764C Highly absorbable solid preparations containing sitafloxacin and tartaric acid |
| 05/05/2009 | CA2407854C Occlusive transdermal therapeutic system with a non-occlusive backing layer |
| 05/05/2009 | CA2311450C Pharmaceutical aerosol compositions |
| 05/05/2009 | CA2309818C Buffered drug formulations for transdermal electrotransport delivery |
| 05/05/2009 | CA2280931C Matrix-free osteogenic devices, implants and methods of use thereof |
| 05/05/2009 | CA2265774C Antibacterial composition |
| 05/05/2009 | CA2166394C Improved nicotine lozenge and therapeutic method for smoking cessation |
| 04/30/2009 | WO2009055312A1 Process for producing a poloxamer gel |
| 04/30/2009 | WO2009055027A2 Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitate delivery into cells in vivo |
| 04/30/2009 | WO2009055014A2 Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom |
| 04/30/2009 | WO2009054916A2 Oligomer conjugates of lidocaine and its derivatives |
| 04/30/2009 | WO2009054851A1 Specific polyphosphazene-containing three-dimensional bone support implants and mehods for their use |
| 04/30/2009 | WO2009054813A1 Method of delivering an anti-cancer agent to a cell |
| 04/30/2009 | WO2009054743A1 Oral dosage forms comprising licarbazξpine acetate |
| 04/30/2009 | WO2009054551A2 Lipid-modified double-stranded rna having potent rna interference effect |
| 04/30/2009 | WO2009054463A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor |
| 04/30/2009 | WO2009054432A1 Intraorally rapidly disintegrating pharmaceutical composition, and method for production thereof |
| 04/30/2009 | WO2009053937A2 Nano-lipid-based carriers for targeted delivery of viral vectors and process for its production |
| 04/30/2009 | WO2009053934A2 Use of metal astringents for the treatment and prevention of hairy heel warts |
| 04/30/2009 | WO2009053758A1 Anti-malarial pharmaceutical composition |
| 04/30/2009 | WO2009053718A2 Immuno-modulatory composition |
| 04/30/2009 | WO2009053700A1 Modification of nucleic acid-containing biological entities |
| 04/30/2009 | WO2009053601A2 Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
| 04/30/2009 | WO2009053597A2 Novel method for preparing nanoparticles covered with an organic stabilising layer coupled to targeting ligands |
| 04/30/2009 | WO2009053596A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 04/30/2009 | WO2009053594A2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment method |
| 04/30/2009 | WO2009053553A1 Rimonabant 2-methoxyethanol solvate and method for preparing same |
| 04/30/2009 | WO2009053466A1 Long acting injectable formulations |
| 04/30/2009 | WO2009053339A2 Cholesterol derivatives of inhibitors of viral fusion |
| 04/30/2009 | WO2009053106A1 Parathyroid hormone formulations and uses thereof |
| 04/30/2009 | WO2009052942A2 Stabilization of hydrophobic protein therapeutic agents |
| 04/30/2009 | WO2009052628A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | WO2009033039A3 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 04/30/2009 | WO2009028900A3 Oral administration drug comprising clopidogrel besylate |
| 04/30/2009 | WO2009026461A3 Thermo-kinetic mixing for pharmaceutical applications |
| 04/30/2009 | WO2009021017A3 Nucleic acid-lipopolymer compositions |
| 04/30/2009 | WO2009019509A3 Improving skin barrier function |
| 04/30/2009 | WO2009010270A3 Purification of pegylated polypeptides |
| 04/30/2009 | WO2009009067A3 Micelle encapsulation of theropeutic agents |
| 04/30/2009 | WO2008128342A9 Composition for enhancing bone formation |
| 04/30/2009 | WO2008124165A9 Self-assembling nanoparticle drug delivery system |
| 04/30/2009 | WO2008110813A3 Controlled release system |
| 04/30/2009 | WO2008109068A3 A conjugate of insulin and vitamin b12 for oral delivery |
| 04/30/2009 | WO2008102150A3 Composition for combating epistaxis |
| 04/30/2009 | WO2008094834A3 Multi-functional drug carriers |
| 04/30/2009 | WO2008027357A9 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 04/30/2009 | WO2007050369A3 Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 04/30/2009 | WO2007016582A3 Amorphous aprepitant coprecipitates |
| 04/30/2009 | WO2006069782A9 Lipid complexes coated with peg and their use |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111787 Polymer blends for drug delivery stent matrix with improved thermal stability |
| 04/30/2009 | US20090111752 Stable Formulation of Modified GLP-1 |
| 04/30/2009 | US20090111732 Gelling Hydrophobic Injectable Polymer Compositions |
| 04/30/2009 | US20090111730 Polypeptide protracting tags |
| 04/30/2009 | US20090110753 Enzyme-cleavable prodrug compounds |
| 04/30/2009 | US20090110752 Composition for controlling blood glucose and method thereof |
| 04/30/2009 | US20090110743 Porous beta-tricalcium phosphate granules and methods for producing same |